Fortis Healthcare recently released its Fortis Healthcare Q3 results, showing a 22% year-on-year decline in consolidated profit. Although the profit after tax (PAT) reached Rs 197 crore, this figure dropped from Rs 254 crore in the year-ago period. Consequently, the financial landscape reflects both significant operational hurdles and strong underlying revenue growth across its hospital network.

Impact of Exceptional Items on Fortis Healthcare Q3 Results

The reported profit includes a net exceptional loss of Rs 45.9 crore. Primarily, this loss stems from a one-time impact related to new labour codes. Moreover, the company balanced this against a reversal of impairment in an associate firm of Rs 9.4 crore. Meanwhile, revenue performed exceptionally well, increasing to Rs 2,265 crore compared to Rs 1,928 crore in the prior fiscal year. Therefore, the core business remains robust despite the temporary bottom-line pressure caused by regulatory adjustments.

Clinical Growth and Expansion Strategy

Fortis Healthcare MD and CEO, Ashutosh Raghuvanshi, highlighted healthy growth in key specialties during the quarter. Specifically, renal sciences and orthopedics grew by 27% and 20%, respectively, over the previous period. Furthermore, the company is actively expanding its footprint in Bengaluru through recent acquisitions. This move strengthens its presence from 900 beds to a potential capacity of over 1,500 beds. Additionally, management is evaluating further inorganic opportunities within existing clusters to sustain clinical momentum.

Frequently Asked Questions

Q1: What caused the decline in Fortis Healthcare\'s Q3 net profit?

The profit decline was primarily due to an exceptional loss of Rs 45.9 crore, which was linked to the one-time impact of new labour codes.

Q2: How did the revenue perform during the December 2025 quarter?

Revenue increased significantly to Rs 2,265 crore, representing a healthy rise from Rs 1,928 crore in the same quarter of the previous year.

Q3: Which medical specialties saw the most growth in this period?

Renal sciences and orthopedics were the top-performing specialties, growing by 27% and 20% respectively, indicating high demand for these clinical services.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Fortis Healthcare Q3 Results: Net profit falls 22% to Rs 197 crore - ETHealthworld


2. Fortis Healthcare Limited - Investor Presentation Q3 FY26


3. Ministry of Labour and Employment - Impact of New Labour Codes on Corporate Earnings 2026